OraSure Technologies, Inc. (NASDAQ:OSUR) Shares Sold by Systematic Financial Management LP

Systematic Financial Management LP decreased its position in shares of OraSure Technologies, Inc. (NASDAQ:OSUR) by 1.3% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,089,748 shares of the medical instruments supplier’s stock after selling 14,440 shares during the period. Systematic Financial Management LP owned 1.47% of OraSure Technologies worth $4,642,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of OSUR. SG Americas Securities LLC purchased a new position in shares of OraSure Technologies during the 1st quarter valued at $72,000. Mackenzie Financial Corp acquired a new position in OraSure Technologies in the second quarter worth about $72,000. Tocqueville Asset Management L.P. raised its position in OraSure Technologies by 20.0% in the first quarter. Tocqueville Asset Management L.P. now owns 15,089 shares of the medical instruments supplier’s stock worth $93,000 after purchasing an additional 2,512 shares in the last quarter. Shikiar Asset Management Inc. bought a new stake in OraSure Technologies during the second quarter worth about $96,000. Finally, SkyView Investment Advisors LLC grew its stake in OraSure Technologies by 100.0% during the second quarter. SkyView Investment Advisors LLC now owns 24,000 shares of the medical instruments supplier’s stock worth $102,000 after buying an additional 12,000 shares during the last quarter. Institutional investors own 93.50% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have recently weighed in on OSUR shares. StockNews.com downgraded OraSure Technologies from a “buy” rating to a “hold” rating in a research note on Saturday, August 17th. Evercore ISI increased their target price on OraSure Technologies from $4.50 to $5.00 and gave the stock an “in-line” rating in a report on Wednesday, August 7th. Three investment analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $6.67.

OraSure Technologies Stock Up 0.7 %

Shares of OraSure Technologies stock opened at $4.29 on Monday. OraSure Technologies, Inc. has a twelve month low of $3.91 and a twelve month high of $8.45. The stock has a market cap of $317.28 million, a price-to-earnings ratio of 14.30 and a beta of 0.05. The company’s fifty day moving average is $4.32 and its 200 day moving average is $4.84.

OraSure Technologies (NASDAQ:OSUR) last announced its quarterly earnings data on Tuesday, August 6th. The medical instruments supplier reported $0.03 earnings per share for the quarter. The firm had revenue of $54.34 million for the quarter, compared to analyst estimates of $53.35 million. OraSure Technologies had a net margin of 9.88% and a return on equity of 9.15%. As a group, equities analysts anticipate that OraSure Technologies, Inc. will post -0.11 earnings per share for the current fiscal year.

OraSure Technologies Company Profile

OraSure Technologies, Inc, together with its subsidiaries, provides point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services in the United States, Europe, and internationally. The company’s products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D.